Abstract
Several studies using transgenic mouse models of familial amyotrophic lateral sclerosis (ALS) have reported a life span increase in exercised animals, as long as animals are submitted to a moderate-intensity training protocol. However, the neuroprotective potential of exercise is still questionable. To gain further insight into the cellular basis of the exercise-induced effects in neuroprotection, we compared the efficiency of a swimming-based training, a high-frequency and -amplitude exercise that preferentially recruits the fast motor units, and of a moderate running-based training, that preferentially triggers the slow motor units, in an ALS mouse model. Surprisingly, we found that the swimming-induced benefits sustained the motor function and increased the ALS mouse life span by about 25 days. The magnitude of this beneficial effect is one of the highest among those induced by any therapeutic strategy in this disease. We have shown that, unlike running, swimming significantly delays spinal motoneuron death and, more specifically, the motoneurons of large soma area. Analysis of the muscular phenotype revealed a swimming-induced relative maintenance of the fast phenotype in fast-twitch muscles. Furthermore, the swimming programme preserved astrocyte and oligodendrocyte populations in ALS spinal cord. As a whole, these data are highly suggestive of a causal relationship not only linking motoneuron activation and protection, but also motoneuron protection and the maintenance of the motoneuron surrounding environment. Basically, exercise-induced neuroprotective mechanisms provide an example of the molecular adaptation of activated motoneurons.
Amyotrophic lateral sclerosis is a chronic neurodegenerative disease characterised by a progressive motor weakness originating from selective motoneuron cell death. On average, mortality occurs within the 4 years following the occurrence of the first clinical symptoms. The currently available therapy extends survival in humans by approximately 3 months. Thus, developing new therapeutic strategies for ALS is of paramount importance. Mutations in superoxide dismutase 1 (SOD1) have been observed in about 20% of familial ALS patients (Rosen, 1993). SOD1 normally converts superoxide ion, a by-product of mitochondrial metabolism, to water and hydrogen peroxide. Despite the fact that SOD1 activity impairment has been ruled out as the causal event of the disease (Shefner et al. 1999), there is some evidence for a gain in toxic function with the mutant form of SOD1 (Boillée et al. 2006). The clinical and morphological abnormalities are common to familial and other forms of ALS, suggesting a common degeneration mechanism. Yet, in spite of the wide variety of possible causes for ALS, including environmental agents, oxidative stress, disturbance of the glutamatergic neurotransmission, a large amount of literature data correlates neuronal cell death to glutamatergic excitotoxicity (Heath & Shaw, 2002). Interestingly, the deleterious effects of glutamatergic excitotoxicity might be decreased by submitting mice to physical exercise training (Carro et al. 2000, 2001). These beneficial effects have been linked to an exercise-induced increase in circulating IGF-1 uptake by neurons (Carro et al. 2001). Furthermore, several groups have reported beneficial effects of a moderate running-based training in ALS mouse models including a 10- to 24-day increase in the life span of mutant mice submitted to training in comparison to their sedentary counterparts (Kirkinezos et al. 2003; Veldink et al. 2003; Liebetanz et al. 2004; Kaspar et al. 2005). It should be noted, however, that one study reported deleterious effects of high-intensity exercise in ALS mice (Mahoney et al. 2004).
Whether there is an exercise-induced neuroprotection is still a matter of debate. According to Veldink et al. (2003), the analysis of the spinal cord anatomy of trained vs untrained mice revealed no difference in neuron distribution and survival. In contrast, Kaspar et al. (2005) reported that physical exercise significantly protected motoneurons from death. These contradictory data concerning the effects of exercise in neuroprotection outline the specific effect exerted by any given exercise protocol i.e. treadmill running for Veldink et al. (2003) and wheel running for Kaspar et al. (2005). Furthermore, although the molecular mechanism(s) underlying the exercise-induced effects is still unknown, the latter results do show that the effect of IGF-1 delivery and exercise are mediated through different molecular mechanisms, which in combination result in synergistic survival (Kaspar et al. 2005). If the exercise-induced neuroprotection is not reflecting the action of diffusible factors, such as IGF-1, then, which mechanism(s) could account for both the generally increased resistance of exercised motoneurons to cell death and the specific effect of a given exercise protocol? One cue for resolving this controversy may be to consider a causal link between the motoneuron activation, the adaptation of neuron intrinsic properties and neuroprotection. Indeed, the activation level of selected motoneuron sub-populations is dependent on the exercise type as shown by Grondard et al. (2008). Briefly, a swimming-based program was associated with high hindlimb movement amplitude and frequency exercise (4.86 ± 0.40 cm and 373.9 ± 47.6 cycles min−1) preferentially activating a sub-population of large motoneurons (with soma area greater than 700 μm2) and a running-based training, described as a low hindlimb movement amplitude and frequency exercise (3.79 ± 0.23 cm and 234.2 ± 24.5 cycles min−1), preferentially activating a sub-population of small motoneurons (with soma area less than 300 μm2). Furthermore, only specific sub-populations of small lumbar motoneurons (<300 μm2) adapted their electrophysiological properties in running rats (Beaumont & Gardiner, 2002). Thus, an essential requirement would be to test whether motoneuron activation leads to their specific resistance to ALS-induced cell death, in contrast to resting neurons.
To directly address the importance of exercise intensity regulation and the existence of an exercise-induced neuroprotection in ALS mice, we have compared the efficiency of either a daily swimming- or running-based training, on the basis of our previous experiments on control mice (Grondard et al. 2008). We provide experimental evidence suggesting a relationship between exercise-induced motoneuron activation and their subsequent protection. Furthermore, our data revealed an unexpected link between exercise-induced neuroprotection and the maintenance of the motoneuron cell environment, in particular, the astrocytes that have been recently pointed out as regulators of ALS progression (Yamanaka et al. 2008).
Methods
Mice
The care and treatment of animals followed the national authority (Ministere de la Recherche et de la Technologie, France) guidelines for the detention, use and the ethical treatment of laboratory animals. All experimental procedures which include minimizing the number of animals used and their suffering were approved by the policies of the French Agriculture and Forestry Ministry.
Transgenic male mice with the G93A human SOD1 mutation B6SJL-Tg (SOD1-G93A) 1Gur/J (ALS mice) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Male mice B6SJL (Janvier, le Genest, France) served as control for this mutant strain.
Disease onset was defined as the time corresponding to the first observation of myotony symptoms in the mice hind limb. Death was scored when mice were unable to stand on their feet 30 s after having been placed on their side. Then, the moribund mice were killed with CO2.
All the experiments using mice were performed in a blind systematic fashion so as to minimize bias.
Training protocol
At 70 days of age, colour randomly assigned transgenic male were trained 30 min a day, 5 days a week as performed in previous studies using ALS mice (Kirkinezos et al. 2003; Veldink et al. 2003). Training was performed until 115 days of age or until death. Twenty ALS mice (running ALS) were submitted to a running-based training on a speed-regulated treadmill (max. 13 m min−1) and 25 ALS mice (swimming ALS) were submitted to a swimming-based training in an adjustable-flow swimming pool (max. 5 l min−1), as previously described (Grondard et al. 2008). A third group of 50 ALS mice (sedentary ALS) and 10 control mice were placed in the pool without flow (25 ALS mice and 5 controls) and floated at the water surface accordingly exhibiting a poor activity or on the treadmill without speed (25 ALS mice and 5 controls). Likewise, these untrained animals which were studied in parallel only displayed an exploratory activity for the whole duration of training of the previously described animal groups.
Core body temperature was determined using a calibrated digital thermometer (Fischer Scientific Company) equipped with a rectal probe designed for rodents.
Behavioural study
General characteristics of mice were given using weight, forelimb grip strength and spontaneous activity (n= 8 in each group). Sedentary and trained mice between 70 and 126 days old were tested once a week and all of the tests were performed blindly (the group assignment being unknown to the observers). The time during which the animals were able to sustain their weight holding onto a metal rail suspended in midair was recorded with the maximum time being 180 s. Each mouse was subjected to three trials with at least a 10 min resting period between tests. The ambulatory behaviour was assessed in an open-field test. The apparatus consisted of a wooden box measuring 50 cm × 50 cm × 20 cm. The floor of the arena was divided into 25 equal squares of 10 cm. Squares adjacent to walls were referred to as periphery and the nine remaining squares were referred to as centre. The mice were tested individually and the open field was washed after each session. Each mouse was placed in a central square on the open field and was allowed to move freely for 5 min. The number of peripheral and central square crossings was scored manually by the experimenter.
Histological evaluation
Mice at 115 days old (n= 8 in each group) were anaesthetized by intraperitoneal injection of 3.5% chloral hydrate and perfused transcardially with buffered saline and 4% paraformaldehyde. The L1 to L5 lumbar region of the spinal cord was processed for vibratom sectioning at 40 μm thickness and one out of every six sections was subsequently processed for immunostaining on free-floating sections. The immunohistochemical analysis was based on detection of choline acetyl-transferase (goat anti-ChAT, 1/800, Chemicon International, Temecula, CA, USA) to stain motoneurons, glial fibrillary acidic protein (rabbit anti-GFAP, 1/100, Dako, Glostrup, Germany) to stain astrocytes, carbonic anhydrase II (rabbit anti-CA II, 1/100; Ghandour et al. 2000) to stain oligodendrocytes and nestin (mouse anti-nestin, 1/300, Chemicon International) to stain neural progenitor cells (NPCs). Secondary antibodies used were donkey anti-species-specific antibodies associated with the fluorophores Alexa Fluor 568 anti-goat IgG (1/500, Molecular Probes), Alexa Fluor 488 anti-rabbit (1/500, Jackson-Immunoresearch laboratories, West Grove, PA, USA) and Cy2 anti-mouse (1/500, Jackson-Immunoresearch laboratories). Sections were mounted in Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA) and visualized using a BX51 Olympus microscope and Q Imaging Fast 1394 Retiga 2000 R camera.
For each mouse, 10 sections of lumbar spinal cord were studied. All cells were counted from within the ventral horn below a lateral line across the spinal cord and from the basis of the central canal. Only neuronal cells with the presence of a nucleolus located within the nucleus were counted. Motoneuron soma areas were evaluated using Image J v1.33 software (National Institutes of Health, Bethesda, MD, USA).
Muscle typology immunofluorescence
At 115 days old (n= 5), soleus, plantaris and tibialis muscles were frozen in isopentane cooled in liquid nitrogen and transverse 10 μm cryostat sections were used for muscle typology. Fresh-frozen sections of each muscle were fixed with acetone and incubated with mouse antibodies raised against myosin heavy chains (MyHC): NCL-MyHCs (anti-MyHC I, slow), NCL-MyHCf (anti-MyHC II, fast) (Novocastra, Newcastle, UK), A4.74 (anti-MyHC IIa) and BF.F3 (anti-MyHC IIb) (DSHB, IA, USA) at a dilution of 1 : 20. Secondary antibodies used were rabbit anti-species-specific antibodies conjugated with Cy2 or Cy3 (1 : 20, Dako). Sections were visualized as described above. For each mouse, three sections of each muscle were studied. Each MyHC count and soma areas were evaluated using Image J v1.33 software. The percentage of fibre IIx was determined as the difference between the total number of type II fibres and the sum of type IIa and IIb fibres [IIx = II − (IIb + IIa)].
Apoptosis evaluation
For immunohistochemical analysis, the activated caspase-3 was detected by a rabbit anti-activated caspase-3 antibody (1 : 20, Chemicon International) and motoneurons were detected as described above. Donkey anti-species-secondary antibodies were associated with the fluorophores Alexa Fluor 568 anti-goat IgG (1 : 500, Molecular Probes) and Alexa Fluor 488 anti-rabbit (1 : 500, Jackson-Immunoresearch).
For Western blot analysis, the ventral horn part of the lumbar spinal cord of 115-day-old mice (n= 3 in each group) was frozen in isopentane and lysed with RIPA buffer supplemented with protease inhibitors (20 mm orthovanadate, 25 mm pyrophosphate; Sigma, Saint Quentin, Fallavier, France). Protein concentration of the clarified homogenates (4°C, 15 min, 12 000g) was determined using the Bradford protein microassay procedure (Biorad Laboratories, Hercules, CA, USA). After addition of a loading buffer, protein samples were electrophoresed on a 10% SDS–polyacrylamide gel and transferred on to PVDF membranes (Biorad Laboratories). The activated caspase-3 was detected with an antibody specific for cleaved forms of caspase-3 (1 : 1000, rabbit anti-activated caspase-3, Promega, Madison, WI, USA) and revealed with a goat peroxidase-conjugated secondary antibody directed against rabbit immunoglobulins (1 : 7500, Jackson Immunoresearch). Bound antibody complexes were developed using the ECL plus kit and exposed to hyperfilm ECL-plus X ray film (Amersham Biotech, Les Ulis, France). After stripping, membranes were incubated with a mouse anti-glyceraldehyde-3-phosphate dehydrogenase monoclonal antibody (1 : 5000, Chemicon International) and revealed with a goat peroxidase-conjugated secondary antibody directed against mouse immunoglobulins (1 : 5000, Jackson Immunoresearch).
Statistical analysis
For the behavioural study, data are presented as mean and standard error of mean (n= 8). A one-way ANOVA for repeated measures with Tukey's post hoc analysis was performed on the data. For the other studies, all values are displayed as means and standard deviation within each group. A Kolmogorov–Smirnov normal distribution analysis was performed on all data followed by either a Student's t test for normally distributed data or a non-parametric Kruskal–Wallis test, to verify significant differences between groups (Systat v 8.0, SPSS Inc., Chicago, IL, USA). All the analyses have been statistically powered to ensure significant scientific statements. All the data presented in this study have a statistical power of 90% (AnaStats.fr, France).
Results
Life span extension and behavioural improvement depend on the exercise type in ALS mice
We submitted two populations of ALS mice to a daily swimming- or running-based training, on the basis of our previous experiments on control mice (Grondard et al. 2008). These protocols started in the asymptomatic phase of the disease (70 days). The swimming programme resulted in the significant delay of 16 days (P < 0.001) for the appearance of symptoms, from 93 ± 8 days in sedentary ALS mice to 109 ± 15 days in swimming ALS mice (Fig. 1A). Furthermore, the mean survival increased from 127 ± 9 days in sedentary ALS mice to 153 ± 24 days in swimming ALS mice, corresponding to an improvement of 25 days (P < 0.01) in the survival of ALS mice (Fig. 1B). In contrast, no effect on the appearance of symptoms or in survival could be recorded with the running-based training.
In order to evaluate the motor function benefits induced by each exercise programme, we subjected the mice of each group to a grip test and to an open field test. All ALS mice presented a reduced body weight compared to controls (Fig. 1C). The weight of sedentary and running ALS mice decreased from 112 days until death. In contrast, the weight of the swimming ALS mice remained constant until 120 days (P < 0.05). In the grip test, the average time sedentary and running ALS mice could sustain their weight using their forelimb muscles decreased from 105 days and these mice were unable to grip after 119 days (Fig. 1D). In contrast, the swimming ALS mice had enough strength to grip for a time comparable to controls, up to 119 days (P < 0.05). Near death, the swimming ALS mice showed difficulties to sustain the grip.
We then compared the spontaneous activity of the mice in an open field test (Fig. 1E). A significant decrease in locomotion activity was found in running ALS from 91 days of age and in sedentary ALS mice from 105 days of age when compared to controls (P < 0.05). In contrast, the swimming ALS mice maintained a near to normal locomotion activity until 112 days of age.
Motoneuron protection depends on the exercise type
The comparison of the lumbar motoneuron populations in the trained and sedentary ALS mice at 115 days of age showed remarkable differences in the neuroprotective potentials of each exercise (Fig. 2). A dramatic motoneuron loss was recorded in the ventral horns of the sedentary and the running ALS mice with a 49% and 45% reduction, respectively (Fig. 2B). Likewise, the motoneuron distribution in sedentary and the running ALS mice exhibited a decrease in the proportion of motoneurons exhibiting medium (between 300 and 700 μm2) and large (greater than 700 μm2) soma in comparison to control mice, with a slight reduction in the absolute number of motoneurons exhibiting soma larger than 500 μm2 (Fig. 2C). As a consequence, an increased proportion of motoneurons exhibiting small soma area (less than 300 μm2) was observed. In contrast, the swimming-based training in ALS mice exhibited a neuroprotective potential with only a 28% reduction of motoneurons in comparison to controls. Interestingly, the swimming-induced protection from neuronal loss was readily apparent for motoneurons exhibiting medium size soma (between 300 and 700 μm2).
The relative maintenance of the muscle phenotype is also dependent on the exercise type
Since muscle weakness is a major cause of disability in ALS, we investigated whether the running- and the swimming-induced protection of motoneurons led to the maintenance of the muscle phenotype. Our count of neurons was performed in the lumbar spinal cord from which the sciatic nerve originates, then we analysed the phenotype of three muscles of the calf innervated by the sciatic nerve, namely two extensor muscles of the ankle, the slow-twitch soleus and the fast-twitch plantaris, and a flexor muscle of the ankle, the fast-twitch tibialis. According to all the phenotypic criteria we used (i.e. the number of myofibres, their cross-section area and the muscle typology), only the swimming-based training efficiently preserved the ALS muscle phenotype close to the corresponding control muscles (Fig. 3). The ALS muscles displayed a significant hypoplasia that appeared particularly severe for the slow-twitch soleus, suggesting that the level of muscular impairment was related, at least in part, to the muscle type (Fig. 3A). Unlike running, swimming efficiently counteracted the hypoplasia in the soleus. Furthermore, the ALS soleus muscle displayed a dramatic atrophy that was rescued by both training programmes (Fig. 3D). In the fast-twitch muscles, only the fast IIb fibres were atrophied in ALS mice. Both exercises limited this atrophy. In sedentary ALS fast-twitch muscles, we found a significant fast-to-slow transition from fast-twitch type II fibres to slow-twitch type I fibres and, within the type II fibre population, from type IIb/IIx to IIa fibres, concurring with the findings of Hegedus et al. (2008) (Fig. 3C). In contrast, the typology of the slow-twitch soleus indicated a slow-to-fast transition. The running programme induced opposite effects on the three muscle typology, counteracting the fast-to-slow transition in the tibialis, but worsening those of the plantaris, leading to a decrease of type IIb fibres and being unable to correct the slow-to-fast transition in the soleus. However, the swimming-based training led to the maintenance of muscle typology in all three muscles.
Exercise-induced control of non-neuronal spinal cell populations in ALS mice
Several studies support the hypothesis that multiple cell types drive the motor degeneration in ALS mice, in association with a direct damage of motoneurons (Hall et al. 1998; Yamanaka et al. 2008). We therefore analysed the influence of each exercise mode on the cell types that lay beyond the motoneurons in ALS mice at 115 days of age. We first analysed the astrocyte population in the spinal cord of control mice and sedentary, running and swimming ALS mice (Fig. 4A). Astrogliosis and astrocytic activation as assessed by using GFAP immunostaining were significantly increased in sedentary and running ALS mice. A significant increase in astrocyte density was noted throughout the lumbar spinal cord (about 40% in sedentary and running ALS mice and only 3% in swimming ALS mice), with a high concentration in the ventral horn (Fig. 4B). Furthermore, compared with the long, thin, filament-like GFAP staining observed in controls, GFAP staining in ALS astrocytes was more condensed and brightly fluorescent, although the filaments often appeared shorter in length. In contrast, no significant astrogliosis was detected in the swimming ALS mice. We secondly evaluated the oligodendrocyte population, on a type II carbonic anhydrase immunostaining basis (Fig. 4C). We found a 30% decrease in oligodendrocytes in the ventral spinal cord of sedentary and running ALS mice compared with controls (Fig. 4D). Interestingly, the swimming-based training led to the maintenance of the oligodendrocyte population in the ALS spinal cord. Finally, we evaluated the neural progenitor cells (NPC) population through the count of nestin-positive cells (Fig. 4E). We observed a significant increase in NPCs throughout the spinal cord of sedentary ALS mice compared to a very discrete presence of NPCs in controls, in agreement with previous studies (Chi et al. 2006). The running- and the swimming-based training induced a significant decrease in the number of NPCs, with, respectively, a 39% and a 58% reduction compared to sedentary ALS mice.
The swimming programme limits apoptosis in the lumbar spinal cord of ALS mice
To verify whether the swimming-based training limits the apoptosis process in the spinal cord of ALS mice, we evaluated the activation of the caspase pathway at 115 days of age. The quantification of the active form of caspase-3 in the ventral spinal cord of sedentary ALS mice showed that the apoptosis process was limited in swimming-trained compared to sedentary and running-trained ALS spinal cords (Fig. 5).
Exercise protocols do not modify body core temperature
A difference between the two exercise conditions could be a change in core temperature during exercise and this could influence neuroprotective mechanisms (Dietrich et al. 2009). The core body temperature was determined in 12 trained control animals. No significant difference in body temperature of the trained control mice was found before (T0) and after training (T30) (Fig. 6).
Discussion
This study provides evidence for significant beneficial effects of forced swimming on the life span of ALS mice as well as on the associated clinical symptoms. Survival was extended by about 20% of life span, which can be considered as one of the best treatments tested on ALS animals when starting at the onset of symptoms (Carri et al. 2006).
In our exercise conditions, swimming can be described as a high movement amplitude and frequency exercise, and running as a low movement amplitude and frequency exercise (Grondard et al. 2008). Accordingly, swimming preferentially activates large motoneurons, belonging to fast motor units (i.e. a medium- and large-size soma motoneuron and a great number of large diameter muscle fibres, of the faster type II) and, in contrast, running preferentially activates small motoneurons belonging to slow motor units (i.e. a motoneurons of small soma area and a low number of type I muscle fibres). Here, we show that swimming, in striking contrast to running, preferentially protects medium-size motoneurons (between 300 and 700 μm2) in ALS spinal cord but not the smaller ones (less than 300 μm2). Taken together, these data strongly suggest that the exercise-activated neurons are selectively protected against cell death, in contrast to resting neurons. Accordingly, the running programme led to a limited neuroprotection that is mainly observed for the motoneurons of small soma area (less than 300 μm2). These data account for the evolution of the muscular phenotype in three skeletal muscles differing in their nature and function. Only the swimming-based training was able to completely counteract the hypoplasia detected in all muscles and notably in the soleus that unexpectedly appeared affected by a severe lost of muscle fibres. Furthermore, only the swimming-based training led to the maintenance of the faster myofibre population to a level comparable to controls in the three tested muscles. Taken together, these results account for the swimming-induced enhancement of the fast motor-unit activity, probably leading to their maintenance and finally to their protection. Interestingly, both exercise programmes displayed comparable potential to counteract the muscular atrophy favouring the hypothesis of an exercise-induced production of a muscle trophic diffusible factor.
Consequently, the molecular mechanism(s) underlying swimming-induced neuroprotection reflects not so much the modulated expression of a diffusible factor, such as IGF-1, which would have indiscriminately protected the whole neuron population by an endocrine or paracrine way, but an intrinsic modification of activated neurons. This concurs with the result of Kaspar et al. (2005) showing distinct molecular mechanisms of action between the IGF-1 delivery and exercise, which, in combination, results in synergistic survival. In addition, the differential exercise effects found in the present study are unlikely to come from a difference in exercise intensity. Indeed, our swimming protocol, a high movement frequency and amplitude exercise when compared to our running protocol (Grondard et al. 2008), should be detrimental according to Mahoney et al. (2004). In striking contrast with this assumption, swimming induced beneficial effects whereas running did not. Repeated electrical activation of the same neuronal network might induce an intrinsic modification of the transcriptome of activated cells, as previously reported in a study of running-induced adaptations in rats showing that only the subpopulation of motoneurons of small soma area displayed an adaptation of their electrophysiological properties (Beaumont & Gardiner, 2002). According to our present results, it can be assumed that this neuronal subpopulation probably corresponds to the motoneurons specifically activated by the running exercise. In the specific case of ALS, the transcriptome modification of the selectively activated motoneuron may lead to an efficient protection against degeneration.
An alternative and non-exclusive mechanism that could be suggested to explain the specific neuroprotection induced by the swimming-based exercise implies an intrinsic modification of the energy metabolism in recruited muscles. On the one hand, the energy metabolism was shown to be highly dysfunctional in the whole organism of ALS mice (Dupuis et al. 2004; Fergani et al. 2007). On the other hand, the muscle might be a primary target site for ALS (Dobrowolny et al. 2008). In addition, the neuromuscular disruption, especially the post-synaptic cleft, appeared as the most prominent event that induces motoneuron death (Frey et al. 2000; Fischer et al. 2004). Thus, a strength training programme would modify the metabolism of the whole organism, more particularly in the muscle, where the swimming-induced preferential utilization of the glycolytic metabolism would entail a decrease in the reactive oxygen species (ROS) production that could be highly relevant in the ALS context of SOD1 mutation. Accordingly, a running-based training might preferentially use the aerobic metabolism that could worsen the ALS phenotype in particular conditions, such as those used by Mahoney et al. (2004). This hypothesis is substantiated by recent evidence suggesting beneficial effects of ROS reduction for skeletal muscles specifically expressing the mutated SOD1(G93A) protein (Dobrowolny et al. 2008).
Furthermore, we reported here, for the first time, that exercise impacts on all neural cell distribution in ALS spinal cord with an efficiency dependent on the nature of the exercise. Only the swimming-based training was able to limit the ALS-induced astrogliosis, reducing both proliferation and hypertrophic processes. Importantly, mutant SOD1 damage in astrocytes was recently shown to accelerate ALS disease progression (Yamanaka et al. 2008). Our data are indicative of a strong relationship between neuroprotection rate and astrocyte preservation, suggesting that the swimming-based training promotes cell survival not only on the motoneuron, but also on its surrounding cellular environment resulting in the maintained integrity of functional neuronal circuits. We also observed that the swimming-based training specifically promoted a significant maintenance of the oligodendrocyte population, which displayed a 30% loss in sedentary and running ALS mice. While the role of oligodendrocytes in motoneuron and axonal degeneration in ALS remains elusive, a significant loss of large myelinated fibres in the corticospinal tract and ventral roots was observed in human ALS (Delisle & Carpenter, 1984). Furthermore, myelin degradation in endstage mice has furthermore been observed in the SOD1(G93A) model (Neusch et al. 2007). It is thus tempting to speculate that the corticospinal fibres involved in the neuronal network specifically activated by the swimming-based training are also protected. In contrast to the differentiated neural cells, neurons and glia, the neural progenitor cell (NPCs) proliferation, which was enhanced in ALS spinal cord, as previously described (Chi et al. 2006; Juan et al. 2007), was strongly inhibited by both running and swimming programmes. The fact that both exercises have the same impact on the exercise-induced loss of NPCs suggested a common mechanism, probably associated with the emission of a diffusible factor.
The importance of physical exercise in maintaining nervous system health and function has consistently emerged as a key factor of plasticity and cell survival but the mechanisms underlying the exercise-induced benefits still remain unclear. The present data strongly suggest that some of the exercise effects are specifically and directly exerted on activated motoneurons which probably adapt their proteome, becoming thus selectively more resistant to apoptosis. This concept has been recently substantiated in a spinal-muscular-atrophy model mouse in our laboratory (Biondi et al. 2008). Thus, analysing the molecular response of activated motoneurons to exercise and, more precisely, the modulation and activation of the cell-surface receptors is most likely to constitute a milestone in discovering relevant means of preventing motoneuron death in ALS.
Acknowledgments
The authors wish to thank C. L. Gallien for comments and advice, V. Mouly for the muscle antibodies and Q. Y. Zheng for helping in the animal model selection. This project was supported by the Association Française contre les Myopathies (AFM). O.B. and C.G. are the recipients of student fellowships from the Ministere de la Recherche et de la Technologie.
Glossary
Abbreviations
- ALS
amyotrophic lateral sclerosis
- CA II
carbonic anhydrase II
- ChAT
choline acetyl-transferase
- GFAP
glial fibrillary acidic protein
- IGF-1
insulin-like growth factor 1
- MyHC
myosin heavy chain
- NPCs
neural progenitor cells
- ROS
reactive oxygen species
- SOD1
superoxide dismutase 1
Author contributions
S.D. conducted, designed and analysed the majority of experiments. J.B. and O.B. conducted the Western blot experiments. C.G. designed, and conducted partly, the training programme and the behavioural analyses. S.L. and C.P. assisted in the majority of experiments and C.P. helped in writing the manuscript. P.L. and P.P.V. helped in the analysis of behaviour data and P.L. helped in writing the manuscript. C.C. helped in the analysis of muscle data. F.C. supervised the project and wrote the manuscript.
References
- Beaumont E, Gardiner P. Effects of daily spontaneous running on the electrophysiological properties of hindlimb motoneurones in rats. J Physiol. 2002;540:129–138. doi: 10.1113/jphysiol.2001.013084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Biondi O, Grondard C, Lécolle S, Deforges S, Pariset C, Lopes P, Cifuentes-Diaz C, Li H, della Gaspera B, Chanoine C, Charbonnier F. Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci. 2008;28:953–962. doi: 10.1523/JNEUROSCI.3237-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boillée S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39–59. doi: 10.1016/j.neuron.2006.09.018. [DOI] [PubMed] [Google Scholar]
- Carri MT, Grignaschi G, Bendotti C. Targets in ALS: Designing mutidrug therapies. Trends Pharmacol Sci. 2006;27(5):267–273. doi: 10.1016/j.tips.2006.03.009. [DOI] [PubMed] [Google Scholar]
- Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci. 2000;20:2926–2933. doi: 10.1523/JNEUROSCI.20-08-02926.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci. 2001;21:5678–5684. doi: 10.1523/JNEUROSCI.21-15-05678.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chi L, Ke Y, Luo C, Li B, Gozal D, Kalyanaraman B, Liu R. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells. 2006;24:34–43. doi: 10.1634/stemcells.2005-0076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delisle MB, Carpenter S. Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci. 1984;63:241–250. doi: 10.1016/0022-510x(84)90199-0. [DOI] [PubMed] [Google Scholar]
- Dietrich WD, Atkins CM, Bramlett HM. Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. J Neurotrauma. 2009;26:301–312. doi: 10.1089/neu.2008.0806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Bonconpagni S, Belia S, Wannenes F, Nicoletti C, Del Prete Z, Rosenthal N, Molinaro M, Protasi F, Fanò G, Sandri M, Musarò A. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425–436. doi: 10.1016/j.cmet.2008.09.002. [DOI] [PubMed] [Google Scholar]
- Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159–11164. doi: 10.1073/pnas.0402026101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, René F, Hocquette JF, Meininger V, Dupuis L, Loeffler JP. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res. 2007;48:1571–1580. doi: 10.1194/jlr.M700017-JLR200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232–240. doi: 10.1016/j.expneurol.2003.10.004. [DOI] [PubMed] [Google Scholar]
- Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20:2534–2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghandour MS, Parkkila AK, Parkkila S, Waheed A, Sly WS. Mitochondrial carbonic anhydrase in the nervous system: expression in neuronal and glial cells. J Neurochem. 2000;75:2212–2220. doi: 10.1046/j.1471-4159.2000.0752212.x. [DOI] [PubMed] [Google Scholar]
- Grondard C, Biondi O, Pariset C, Lopes P, Deforges S, Lécolle S, Gaspera BD, Gallien CL, Chanoine C, Charbonnier F. Exercise-induced modulation of calcineurin activity parallels the time course of myofibre transitions. J Cell Physiol. 2008;214:126–135. doi: 10.1002/jcp.21168. [DOI] [PubMed] [Google Scholar]
- Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23:249–256. doi: 10.1002/(sici)1098-1136(199807)23:3<249::aid-glia7>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Heath PR, Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:438–458. doi: 10.1002/mus.10186. [DOI] [PubMed] [Google Scholar]
- Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008;586:3337–3351. doi: 10.1113/jphysiol.2007.149286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Juan L, Dawei Z, Julie AD. Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res. 2007;29:204–209. doi: 10.1179/174313206X152519. [DOI] [PubMed] [Google Scholar]
- Kaspar BK, Frost LM, Christian L, Umapathi P, Gage FH. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol. 2005;57:649–655. doi: 10.1002/ana.20451. [DOI] [PubMed] [Google Scholar]
- Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003;53:804–807. doi: 10.1002/ana.10597. [DOI] [PubMed] [Google Scholar]
- Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci. 2004;20:3115–3120. doi: 10.1111/j.1460-9568.2004.03769.x. [DOI] [PubMed] [Google Scholar]
- Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656–662. doi: 10.1002/mus.20004. [DOI] [PubMed] [Google Scholar]
- Neusch C, Bähr M, Schneider-Gold C. Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease? Muscle Nerve. 2007;35:712–724. doi: 10.1002/mus.20768. [DOI] [PubMed] [Google Scholar]
- Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0. [DOI] [PubMed] [Google Scholar]
- Shefner JM, Reaume AG, Flood DG, Scott RW, Kowall NW, Ferrante RJ, Siwek DF, Upton-Rice M, Brown RH., Jr Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology. 1999;53:1239–1246. doi: 10.1212/wnl.53.6.1239. [DOI] [PubMed] [Google Scholar]
- Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737–743. doi: 10.1016/s0960-8966(03)00104-4. [DOI] [PubMed] [Google Scholar]
- Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251–253. doi: 10.1038/nn2047. [DOI] [PMC free article] [PubMed] [Google Scholar]